The effect of multivitamine on precancerous leision of cervix

Cytopathologic and Colposcopic findings evaluation of supplementation therapy on cervix precancerous lesion

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT2014102719694N1

Enrollment

120

Registered

2015-05-10

Start date

2015-02-17

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervix cancer. Malignant neoplasm of cervix uteri

Interventions

Intervention 1: Mineral and multivitamin and 30 mg per day Q10 during 3 mounts in intervention group. Intervention 2: control group: plasebo.

Treatment - Drugs

Placebo

Mineral and multivitamin and 30 mg per day Q10 during 3 mounts in intervention group

control group: plasebo

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Inclusion criteria: Cervical intraepithelial Neoplasia (CIN1); Atypical cell with HPV positive. Exclusion criteria: CIN2 or more in primary pathology report after biopsy.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Cure of Cin1 lesion. Timepoint: Pre intervention, 6 months after trial. Method of measurement: Pathology report.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDanial Farhadi

Hamadan university of medical sciensces

Danifarhadi20@Gmail.com+98 81 3838 0572

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026